retatrutide fda approval status november 2025 Availability & Timeline How to Get Retatrutide in

However, the severity of gastrointestinal adverse events was mild to moderate [63]

First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) increased 12.02% in March 2025 compared to December 2024

*Data not collected for US respondents What GLP-1 users say is changing: appetite, well-being, and daily habits Across the U.S

Experts generally agree that adequate protein intake and regular strength training are important components of any healthy aging strategy, particularly during periods of weight loss

The safety profile was similar to other incretin-based therapies

Ethics declarations Competing interests H.L.H